Trichostatin A Enhances Differentiation of Human Induced Pluripotent Stem Cells to Cardiogenic Cells for Cardiac Tissue Engineering

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Stem Cells Translational Medicine

• Publication date

  2013-07-24

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.5966/sctm.2012-0161PMID 23884641PMCID PMC3754471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.

  2012cited by this paper
• Elucidation of a Novel Pathway through Which HDAC1 Controls Cardiomyocyte Differentiation through Expression of SOX-17 and BMP2

  2012cited by this paper
• A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions.

  2012cited by this paper
• Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility.

  2012cited by this paper
• Transplantation of Engineered Cardiac Muscle Flaps in Syngeneic Rats

  2012cited by this paper
• Histone Deacetylase 1 Deficiency Impairs Differentiation and Electrophysiological Properties of Cardiomyocytes Derived from Induced Pluripotent Cells

  2012cited by this paper
• Ischemic Preconditioning Promotes Intrinsic Vascularization and Enhances Survival of Implanted Cells in an In Vivo Tissue Engineering Model

  2012cited by this paper
• Dynamic Link between Histone H3 Acetylation and an Increase in the Functional Characteristics of Human ESC/iPSC-Derived Cardiomyocytes

  2012cited by this paper
• Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

  2012cited by this paper
• In vivo tissue engineering chamber supports human induced pluripotent stem cell survival and rapid differentiation.

  2012cited by this paper
• Generation of Induced Pluripotent Stem Cell Lines from Friedreich Ataxia Patients

  2011cited by this paper
• Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.

  2011cited by this paper
• Bioengineering heart muscle: a paradigm for regenerative medicine.

  2011cited by this paper
• Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue

  2011cited by this paper
• Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.

  2010cited by this paper
• Engineering cardiac tissue in vivo from human adipose-derived stem cells.

  2010cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis

  2008cited by this paper
• Trichostatin A induces myocardial differentiation of monkey ES cells.

  2007cited by this paper
• Cardiac Tissue Engineering in an In Vivo Vascularized Chamber

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue

  2006cited by this paper
• HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage

  2006cited by this paper
• Regenerating the heart

  2005cited by this paper
• Histone deacetylase activity is required for embryonic stem cell differentiation

  2004cited by this paper
• Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view.

  2004cited by this paper
• Differentiation of embryonic stem cells into cardiac myocytes

  2002cited by this paper
• Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

  2001cited by this paper
• [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].

  1990cited by this paper
• Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

  1990cited by this paper
• Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Estimation of Action Potential Changes from Field Potential Recordings in Multicellular Mouse Cardiac Myocyte Cultures Key Words Microelectrode Array @bullet Action Potential Upstroke @bullet Action P

  year unknowncited by this paper

• Microencapsulation-based cell therapies

  2022cites this paper
• Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology

  2022cites this paper
• Interactivity of biochemical and physical stimuli during epigenetic conditioning and cardiomyocytic differentiation of stem and progenitor cells derived from adult hearts.

  2021cites this paper
• 4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition

  2021cites this paper
• In Vitro and In Vivo Approaches for Prevascularization of Three-Dimensional Engineered Tissues

  2021cites this paper
• Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer’s Disease

  2021cites this paper
• Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers

  2021cites this paper
• Investigating the role of APOE: limitations of human pluripotent stem cell-derived cerebral organoids

  2020cites this paper
• A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling

  2020cites this paper
• A Tissue Engineering Chamber for Continuous Pulsatile Electrical Stimulation of Vascularized Cardiac Tissues In Vivo

  2020cites this paper
• The effect of sodium valproate on differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in two-dimensional culture and fibrin scaffold conditions

  2019cites this paper
• Epigenetics, cardiovascular disease, and cellular reprogramming.

  2019cites this paper
• Mitochondrial Fusion by M1 Promotes Embryoid Body Cardiac Differentiation of Human Pluripotent Stem Cells

  2019cites this paper
• Epigenetic Pharmacology in Regenerative Medicine (Epi-Drugs)

  2019cites this paper
• Mitochondrial fi ssion protein Drp1 inhibition promotes cardiac mesodermal differentiation of human pluripotent stem cells

  2018cites this paper
• Mitochondrial fission protein Drp1 inhibition promotes cardiac mesodermal differentiation of human pluripotent stem cells

  2018cites this paper
• Stem cells and somatic cells reprogramming – selected issues

  2018cites this paper
• Bmi‐1 high‐expressing cells enrich cardiac stem/progenitor cells and respond to heart injury

  2018cites this paper
• The Regenerative Capability of the Urodele Amphibians and Its Potential for Plastic Surgery

  2018cites this paper
• The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin

  2018influential citation
• The Vascularised Chamber as an In Vivo Bioreactor.

  2018cites this paper
• Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency

  2017cites this paper
• A novel protocol to provide a suitable cardiac model from induced pluripotent stem cells.

  2017cites this paper
• Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes

  2017cites this paper
• In Vitro and In Vivo Approaches for Pre-vascularization of 3-Dimensional Engineered Tissues

  2017cites this paper
• Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor

  2017cites this paper
• Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity.

  2016cites this paper
• Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber.

  2016cites this paper
• Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts

  2016cites this paper
• Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy.

  2016cites this paper
• Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing.

  2016cites this paper
• Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.

  2016cites this paper
• Three Dimensional Collagen Scaffold Promotes Intrinsic Vascularisation for Tissue Engineering Applications

  2016cites this paper
• Heart Muscle Tissue Engineering

  2016cites this paper
• 7. Tissue engineering

  2015cites this paper
• Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening

  2015cites this paper
• Cardiac Repair With a Novel Population of Mesenchymal Stem Cells Resident in the Human Heart

  2015cites this paper
• Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.

  2015cites this paper
• Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells

  2015cites this paper
• Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease

  2015cites this paper
• Opracowanie nowej metody generowania ludzkich indukowanych komórek pluripotencjalnych (iPS) i wykazanie roli białka KAP1 w epigenetycznej regulacji procesu samoodnowy

  2015cites this paper
• From Keratinocytes by Simple Transfection of Episomal Vectors Efficient Generation of Integration-Free Human Induced Pluripotent Stem Cells

  2014cites this paper
• Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools

  2014cites this paper
• Histone Deacetylase Inhibitor Induces the Expression of Select Epithelial Genes in Mouse Utricle Sensory Epithelia-Derived Progenitor Cells

  2014cites this paper
• Dual Gene Expression in Embryoid Bodies Derived from Human Induced Pluripotent Stem Cells Using Episomal Vectors

  2014cites this paper
• Vascularisation to improve translational potential of tissue engineering systems for cardiac repair.

  2014cites this paper
• SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.

  2014cites this paper
• Efficient Generation of Integration‐Free Human Induced Pluripotent Stem Cells From Keratinocytes by Simple Transfection of Episomal Vectors

  2014cites this paper
• Cardiac regeneration and diabetes

  2014cites this paper
• Cell and Gene Therapy for Friedreich Ataxia: Progress to Date

  2014cites this paper
• The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation

  2014cites this paper
• Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: Improving the safety of iPS cell transplantation to myocardium

  2014cites this paper
• The effect of biomimetic tissue engineering constructs on the phenotype of immature cardiomyocytes

  2013cites this paper